Arquivos Ozempic® - ElvasIP | Intellectual Property, Trademarks and Patents in 15 Days
9 de December de 2025
Mounjaro®: O novo Blockbuster da Eli Lilly
Published by Elvas IP on 9 de December de 2025
Categories

Mounjaro®: O novo Blockbuster da Eli Lilly enterrará de vez o Ozempic® e conquistará todo o mercado de tratamento do diabetes tipo 2 e de obesidade?

A aprovação do medicamento Mounjaro® pela Agência Nacional de Vigilância Sanitária (ANVISA), em setembro passado, traz uma nova luz para pacientes com diabetes tipo 2 e […]
Do you like it?3
0 Read more
27 de November de 2025
Brazil Challenges Pharmaceutical Giants
Published by Elvas IP on 27 de November de 2025
Categories

Brazil Challenges Pharmaceutical Giants: The “Glamorized” Injection Widely Used for Weight Loss Will Lose Patent Protection in Brazil in the Coming Months

The recent decision of the Federal Regional Court of the 1st Region (TRF-1) to deny the extension of patents in Brazil for medications containing the active […]
Do you like it?2
0 Read more